companies

Acurable

Founded 2016
Employees 15+
Primary contact
25 Wilton Rd
SW1V 1LW London
United Kingdom
Links
https://acurable.com/
Sections
Acurable creates accurate and user-friendly wearable medical devices intended to be used by patients themselves at home. Its award-winning, patented AcuPebble technology enables the automated diagnosis and management of respiratory conditions at home. Acurable's first product AcuPebble SA100 simplifies obstructive sleep apnoea (OSA) detection and monitoring by enabling fully automated testing of patients at home for the first time. In addition to its headquarters in London, the company also has an office in Seville, Spain.
Founded 2016
Employees 15+
Primary contact
25 Wilton Rd
SW1V 1LW London
United Kingdom
Links
https://acurable.com/
Sections

Funding 💰

Total $13.7M
Last round 🔗 €11M
Series A
October 3, 2022.
Select investors Kindred Capital, Alma Mundi Ventures, Ascension, Kibo Ventures

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Science-backed: Acurable builds on the foundation of more than 10 years' research at the Wearable Technologies Lab in Imperial College London by Acurable's founder, Professor Esther Rodriguez-Villegas.
  • Clinically-validated: Acurable's AcuPebble SA100 provides clinically validated and fully automated sleep apnoea detection. It has been tested at a clinical trial at the NHS Royal Free Hospital and at the NHS National Hospital for Neurology and Neurosurgery (UK). 🔗
  • Cost-effective: Acurable's devices increased the number of tests conducted with the same resources. They are simple (require less staff time and resources per test), reliable (reduces invalid tests that must be repeated), and efficient (reduces referral to result waiting times).
  • Better patient experience: AcuPebble is designed to reduce the burden of sleep apnoea testing for patients. It is easy to use by patients at home, minimizing trips to a sleep clinic and overnight stays. Also, it is a non-invasive device that also reduces the waiting time for patients with a simpler (and faster) patient pathway.

Video ▶️

Quotes 💬

“
We are delighted to be joining Acurable's exciting journey. AcuPebble has the potential to transform the way sleep apnoea and other chronic conditions are diagnosed and monitored. It's much more accurate and easier to use than other devices, and we believe it's a huge step forward for global healthcare. This is still just the beginning for Acurable and I cannot wait for what comes next.
— Sonia Fernández, Partner at Kibo Ventures 🔗
Last update: March 17, 2023